InvestorsHub Logo
Followers 5
Posts 1109
Boards Moderated 0
Alias Born 05/02/2014

Re: was CUIN2 post# 25139

Tuesday, 09/08/2015 9:49:08 AM

Tuesday, September 08, 2015 9:49:08 AM

Post# of 140475
There is a benefit to having healthy shareholder value (in a situation like Titan's) that has nothing to do with the stockholders being able to realize investment value.

Fowler and Hargrove have said repeatedly that they are driven to create a system that adds value to the medical scene, both for the users and the patients. That is admirable, but doesn't out any points in the column for how to succeed as a business venture.

In my opinion, the pps of this company is detrimental to seeding the market by developing anticipation among hospital purchasers, and surgical providers. The pps is that of a "shot in the dark" company. The real progress that Titan has made and the real potential of this company is unknown to the medical marketplace, let alone tech investors. If ISRG or Samsung or anyone else gets the word-of-mouth jump on Titan with an upcoming product (even if in reality, years away) it will set Titan back another year and many potential sales.

In my opinion, at this stage of their game, they need to develop anticipation in their potential market that THEY are the one to watch, to prepare budgets for, and to interest surgeons in training.

A pps of pennies over a dollar for Titan is ridiculous. I'm tired of the moral highground stuff from management. They know they have a winner, but no one else does. You just don't reveal the finished product on one grand day (Segway, for example, hasn't been able to capitalize on their revolution). You need to build a base of potential customers.